HEDGE (Hypermobile Ehlers-Danlos Genetic Evaluation) Study

HEDGE Study, the search for the genetic cause of hEDS

1000 individuals with hEDS have been enrolled for whole genome sequencing

RECRUITMENT IS NOW COMPLETE

The Ehlers-Danlos Society is delighted to announce that 1000 individuals with hypermobile Ehlers-Danlos syndrome (hEDS) have been enrolled into the HEDGE study and have given a blood sample. 

The next phase of the HEDGE Study will be the sequencing of DNA samples to obtain data for analysis. The sequencing of samples began in May 2022 at the Broad Institute and will continue as more blood samples are processed and shipped. 

Once sequencing is finalized (this timeframe is not yet known), analysis of data will begin, bringing the medical community one step closer to finding the gene(s) responsible for hypermobile Ehlers-Danlos syndrome.

Have a question?

CLICK HERE FOR FAQ